RECIST 1.1 CRITERIA IN THE ASSESSMENT OF LUNG TUMORS
https://doi.org/10.20862/0042-4676-2017-98-1-36-43
Abstract
The paper considers the main provisions of the 2009 RECIST guidelines (version 1.1.) criteria for a standard approach to measuring lung tumor lesions and assessing the dynamics of the tumor process during treatment. This paper contains a list of conditions for carrying out multislice spiral computed tomography, under which the latter becomes maximally reproducible for the same patient, as well as an assessment of the course of the disease does optimal.
About the Authors
O. N. ChernovaRussian Federation
MD, PhD, Head of Department of Computed Tomography and Magnetic Resonance Tomography
A. V. Vazhenin
Russian Federation
MD, PhD, DSc, Professor, Corresponding Member of Russian Academy of Sciences, Head Physician;
N. V. Fadeeva
Russian Federation
MD, PhD, Head of Department of Anticancer Drug Therapy
A. V. Shopova
Russian Federation
MD, PhD, Radiologist
References
1. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S.,Rubinstein L. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000; 92 (3): 205–16.
2. Eisenhauer E.A., Therasse P., Boga-erts J., Schwartz L.H., Sargent D., Ford R. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur.J. Cancer. 2009; 45: 228–47.
3. Гележе С.П., Морозов С.П., Мандельблат Ю.Э., Либсон Е.И. Современные критерии лучевой диагностики в оценке эффективности специального противоопухолевого лечения. Российский онкологический журнал. 2004; 3: 39–46. [Gelezhe S.P., Morozov S.P., Mandel’blat Yu.E., Libson E.I. Modern criteria of radiodiagnosis in an efficiency evaluation of special anticancer treatment. Rossiyskiy Onkologicheskiy Zhurnal (Russia Oncological Journal). 2004; 3: 39–46 (in Russ.).]
4. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 1997; 111 (6): 1718–23.
5. Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forhcoming seventh edition of the TNM classification for lung cancer.J. Thorac. Oncol. 2009; 4 (5): 568–77. Поступила 24.08.2016
Review
For citations:
Chernova O.N., Vazhenin A.V., Fadeeva N.V., Shopova A.V. RECIST 1.1 CRITERIA IN THE ASSESSMENT OF LUNG TUMORS. Journal of radiology and nuclear medicine. 2017;98(1):36-43. (In Russ.) https://doi.org/10.20862/0042-4676-2017-98-1-36-43